Ezetimibe - PDFSEARCH.IO - Document Search Engine

Ezetimibe
Results: 175

#	Item
121	Original Article POPULATION HEALTH MANAGEMENT Volume 12, Number 5, 2009 ª Mary Ann Liebert, Inc. DOI: [removed]=pop[removed] Add to Reading List Source URL: www.wellnessandpreventioninc.com Language: English - Date: 2014-09-29 07:08:08 Merck Lactones Statins Cardiology Sterols Ezetimibe Hypercholesterolemia Simvastatin Cholesterol Chemistry Medicine Health
122	Endocrinologic and Metabolic Drugs Advisory Committee VYTORIN / ZETIA NDAs[removed]and[removed]James P. Smith, MD, MS Division of Metabolism and Endocrinology Products Add to Reading List Source URL: www.fda.gov Language: English Organic chemistry Schering-Plough Ezetimibe Simvastatin Statin Hypercholesterolemia Low-density lipoprotein Familial hypercholesterolemia HMG-CoA reductase Chemistry Merck Medicine
123	9619511XX HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VYTORIN safely and effectively. See full prescribing information for VYTORIN. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:51:13 Medicine Schering-Plough Statins Lactones Fibrates Ezetimibe Simvastatin Lovastatin Hypolipidemic agent Chemistry Organic chemistry Merck
124	[removed]VYTORIN ® [removed]EZETIMIBE 10 MG/SIMVASTATIN 10 MG TABLETS) VYTORIN ® 10/20 Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:10:08 Merck Cardiology Schering-Plough Statins Sterols Ezetimibe Simvastatin Rosuvastatin HMG-CoA reductase Chemistry Medicine Organic chemistry
125	Medical Assistance Division Medicaid Drug Utilization Review Newsletter 1st Quarter[removed]Volume 4 Issue 1 Add to Reading List Source URL: nmhsd.sks.com Language: English - Date: 2013-12-27 11:59:39 Statins Cardiology Lipoproteins Merck Lactones Low-density lipoprotein Hypercholesterolemia Ezetimibe Fenofibrate Chemistry Organic chemistry Medicine
126	PRESS RELEASE Sanofi and Regeneron to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014 Paris, France, and Tarrytown, NY, August 25, [removed]Sanofi (EURONEXT: SAN and NYSE: SNY) Add to Reading List Source URL: en.sanofi.com Language: English - Date: 2014-10-09 14:57:16 Organofluorides Medicine Pharmaceutical industry Monoclonal antibodies Sanofi Forward-looking statement Ezetimibe Pharmaceutical sciences Regeneron Chemistry
127	Sanofi and Regeneron Present Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress[removed]Alirocumab, an investigational treatment for hypercholesterolemia, showed a 62 percent reduction in LDL-C Add to Reading List Source URL: en.sanofi.com Language: English - Date: 2014-10-10 12:14:27 Clinical research Pharmacology Organofluorides Phenols Ezetimibe Lactams Statin Low-density lipoprotein Familial hypercholesterolemia Medicine Chemistry Health
128	Microsoft Word - FINAL FDA Errata EMDAC[removed]12v2.doc Add to Reading List Source URL: www.fda.gov Language: English Amines Organofluorides Phenols Lactams Ezetimibe Methadone Simvastatin CYP3A4 Chemistry Organic chemistry Merck
129	Research Prioritization Topic Briefs Topics 1-6 PCORI Scientific Program Area: Assessment of Prevention, Diagnosis, and Treatment Options The Johns Hopkins Evidence Based Practice Center Add to Reading List Source URL: www.pcori.org Language: English - Date: 2014-09-10 09:50:35 Merck Cardiology Statins Schering-Plough Fibrates Ezetimibe Rosuvastatin Red yeast rice Hypercholesterolemia Chemistry Organic chemistry Medicine
130	Applying new cholesterol guidelines to a patient population reduces heart attacks, strokes, study finds Add to Reading List Source URL: medicalxpress.com Language: English - Date: 2014-11-28 22:36:10 Nutrition Statin Cholesterol Low-density lipoprotein Atherosclerosis Hypocholesterolemia Ezetimibe/simvastatin Medicine Health Circulatory system

UPDATE